Want to see IN:BLUEJET full AI Analyst Report?
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹325.20 - ₹1,028.20
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹98.55B
Enterprise Value₹86.59B
Total Cash (Recent Filing)₹4.11B
Total Debt (Recent Filing)₹206.29M
Price to Earnings (P/E)39.7
Beta1.45
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)20.33
Shares Outstanding173,465,420
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)4.17
Price to Sales (P/S)5.99
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹370.00Price Target Upside-43.38% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)18.33
Revenue Forecast (FY)₹11.97B
Bulls Say, Bears Say
Bulls Say
High Profitability And MarginsConsistently strong gross and net margins across the cycle indicate durable pricing power and operational efficiency in its API niches. Sustained margins support internal reinvestment, cover fixed costs, and provide resilience to demand swings, underpinning long-term cash generation potential.
Very Conservative Balance SheetExtremely low leverage provides material financial flexibility and low interest burden, enabling the company to fund capex or absorb shocks without refinancing risk. A strong equity base and conservative funding mix enhance solvency and support strategic investment over the medium term.
Niche, Complex API ExpertiseSpecialization in complex chemistries creates high technical barriers to entry and fosters long-term customer stickiness with formulation partners. This structural positioning supports higher-value product mix, potential premium margins, and sustained demand from regulated and semi-regulated markets.
Bears Say
Sharp FY2026 Revenue DeclineA near-20% revenue drop in FY2026 signals durable demand or mix deterioration rather than transient volatility. Loss of scale can erode unit economics, pressure margins and fixed-cost absorption, and complicate medium-term planning for capacity and customer commitments.
Inconsistent Cash Flow And FCFVolatile operating cash flow and uneven FCF reduce visibility into true cash-generative capacity. Recurrent working-capital swings and occasional negative FCF constrain funding for capex, dividends, or debt repayment and raise execution risk over the next several quarters.
Earnings Volatility / EPS ContractionSignificant EPS decline reflects operational and growth headwinds, potentially from mix or demand loss. Persistent earnings volatility undermines reinvestment planning and makes it harder to sustain ROE and shareholder returns, increasing medium-term performance risk.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹325.20 and its highest was ₹1028.20 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹98.55B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is Aug 11, 2026 which is in 38 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on May 25, 2026. The company reported ₹3.7 earnings per share for the quarter, beating the consensus estimate of ₹2.55 by ₹1.15.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.22%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 173,465,420 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹3.7 in its last earnings report, beating expectations of ₹2.55. Following the earnings report the stock price went up 9.522%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
BLUEJET Stock 12 Month Forecast
Average Price Target
₹370.00
▼(-43.38% Downside)
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Jubilant Ingrevia Ltd.
―
Supriya Lifescience Limited
―
Syngene International Ltd.
―